Bristol-Myers Squibb Co. (BMY)
Analysis of Inventory
Accounting Policy on Inventory
Inventories are stated at the lower of average cost or market.
Source: 10-K (filing date: 2019-02-25).
Bristol-Myers Squibb Co., balance sheet: inventory
US$ in millions
|Dec 31, 2018||Dec 31, 2017||Dec 31, 2016||Dec 31, 2015||Dec 31, 2014|
|Work in process||1,026||931||988||646||856|
|Raw and packaging materials||202||273||264||194||204|
|Inventories||Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.||Bristol-Myers Squibb Co.’s inventories increased from 2016 to 2017 and from 2017 to 2018.|